Facts you should know about heterochromia iridis
- Heterochromia iridis is an uncommon condition in which the two eyes are different in color from each other.
- Heterochromia iridis may be congenital (present at birth) or acquired.
- Hereditary heterochromia iridis may be associated with other abnormalities of the eyes or body.
- Acquired heterochromia is usually due to an eye disease.
- If the condition is acquired, treatment may be directed at the underlying cause.
- Colored contact lenses may be used for cosmetic reasons.
- Most cases of heterochromia iridis are mild and do not have associated problems.
What is heterochromia iridis?
Heterochromia iridis is a condition in which the iris in one eye has a different color than the iris of the other eye. The iris is the tissue of the eye that surrounds the pupil and imparts a color, whether green, blue, brown, hazel, grey, or other, to the eye. Heterochromia iridis is to be differentiated from heterochromia (difference in color) iridum (within the iris of one eye).
Iris color is the result of the pigment that is present in the iris. Brown eyes have large amounts of melanin pigment deposits, and blue eyes have a lack of melanin. Although eye color is inherited, the inheritance pattern is complex, with interaction of more than one gene. These genes interact to provide the full constellation of colors. Other genes may determine the pattern and placement of pigment in the iris, thereby accounting for solid brown as opposed to rays of color. Normally, the two irises of an individual are of the same color. In heterochromia, the affected eye may be hyperpigmented (darker or hyperchromic) or hypopigmented (lighter or hypochromic). Eye color is determined primarily by the concentration and distribution of melanin within the iris tissues.
One Cause of Heterochromia Iridis
Parry-Romberg Syndrome
Parry-Romberg syndrome is a rare disorder characterized by slowly progressive deterioration (atrophy) of the skin and soft tissues of half of the face (hemifacial atrophy), usually the left side. It is more common in females than in males.
Initial facial changes usually involve the tissues above the upper jaw (maxilla) or between the nose and the upper corner of the lip (nasolabial fold) and subsequently progress to the angle of the mouth, areas around the eye, the brow, the ear, and the neck. The deterioration may also affect the tongue, the soft and fleshy part of the roof of the mouth, and the gums. The eye and cheek of the affected side may become sunken and facial hair may turn white and fall out (alopecia). In addition, the skin overlying affected areas may become darkly pigmented (hyperpigmentation) with, in some cases, areas of hyperpigmentation and patches of unpigmented skin (vitiligo). Parry-Romberg syndrome is also accompanied by neurological abnormalities including seizures and episodes of severe facial pain (trigeminal neuralgia).
Learn more about Parry-Romberg syndrome »
How rare is heterochromia iridis?
Heterochromia can be present at birth (congenital) or acquired. The incidence of congenital heterochromia iridis is approximately six out of a 1,000, although in most of these cases, it is hardly noticeable and unassociated with any other abnormality.
What are heterochromia iridis symptoms and signs?
The appearance of different coloration between the two eyes is usually the only symptom or sign. Many times the difference is so slight that it is only noticed under certain lighting conditions or in close-up photographs. If inflammation or trauma is the cause, other signs or symptoms may be present. Heterochromia iridis is termed complete when the entire iris in one eye is different in color than that of the other eye. Segmental heterochromia involves only a radial or piece-of-pie-shaped area of one iris. In central heterochromia, there is an inner ring of the iris that is different in color from the rest of the iris. The term heterochromia iridum can be used when the heterochromia is incomplete, as in segmental or central heterochromia.
What are risk factors for heterochromia iridis?
Familial genetic abnormalities, ocular trauma, and inflammation are all risk factors for the development of heterochromia iridis. The use of prostaglandin analogue eyedrops for glaucoma or to stimulate eyelash growth is a modifiable risk factor.
What causes heterochromia iridis?
Heterochromia is classified primarily by its time of onset as either genetic (congenital, present at or shortly after birth) or acquired. Most cases of heterochromia are hereditary, and these may be associated with a congenital syndrome. Other cases are acquired and caused by a disease or due to an injury. Sometimes one eye may change color following certain diseases or injuries. Heterochromia present at or shortly after birth is usually hereditary or due to intrauterine disease or injury. The genetics of eye color determination involves at least eight different genes, with inherited eye color being based on various combinations of gene expression. Congenital heterochromia may be familial and is inherited as an autosomal dominant trait. Environmental or acquired factors can alter these inherited traits. An infant with heterochromia should be examined by both a pediatrician and an ophthalmologist for other possible problems. If another disorder is suspected, diagnostic tests, such as blood tests or chromosome studies, may be done to confirm the diagnosis.
Most cases of heterochromia at birth are genetic and unassociated with any other ocular or systemic abnormality. This is simply called congenital heterochromia iridis. The lighter eye usually shows some loss of iris and therefore is regarded as the affected eye. The lighter iris may be differently colored throughout or only in part.
Congenital syndromes which may be characterized by heterochromia iridis include:
- Waardenburg syndrome, an autosomal dominant genetic condition that can cause hearing loss and changes in coloring of the hair, skin, and eyes.
- "Piebaldism" is similar to Waardenburg syndrome but is unassociated with deafness. People with this condition have patches of depigmented skin on their head and trunk, as well as on their eyebrows, eyelids, eyelashes, and hair. Affected people sometimes have heterochromia iridis.
- Congenital "Horner's syndrome" is not a genetic syndrome, but a group of findings due to birth injury or intrauterine brain injury involving the sympathetic nervous system innervation to one eye. On the affected side, the pupil is small, the lid is drooping, and the iris is lighter. It is not associated with hearing loss or additional pigmentation anomalies.
- Sturge-Weber syndrome, a syndrome characterized by a port-wine stain in the distribution of the trigeminal nerve on the face and tumors known as angiomas of the brain and choroid.
- Neurofibromatosis type 1, also known as von Recklinghausen disease, is a disorder in which there are tumors of nerve cells together with disorders of melanin, causing abnormalities of skin (and eye) pigmentation. Lisch nodules are usually present in the iris. These are clear yellow to brown dome-shaped elevations on the iris and, although they are usually present in both eyes, may be more apparent in one eye.
- Tuberous sclerosis, also known as Bourneville disease, causes nonmalignant tumors in various organs including the eyes.
- Hirschsprung disease, a bowel disorder, may be associated with iris heterochromia due to reduction is iris pigmentation.
- Incontinentia pigmenti, also known as Bloch-Sulzberger syndrome, affects the skin, hair, teeth, nails, and central nervous system. In this condition, the iris may be darker in the affected eye.
- Parry-Romberg syndrome, or progressive hemifacial atrophy, is a condition that causes the breakdown of the skin and soft tissues of half of the face.
Acquired conditions or diseases that may present with heterochromia iridis include:
- The inflammation of iritis or anterior uveitis of any cause, including tuberculosis, sarcoidosis, and herpes simplex, may cause loss of iris pigment in the affected eye.
- Fuchs' heterochromic cyclitis is a condition characterized by a low-grade, asymptomatic uveitis in which the iris in the affected eye becomes hypochromic and has a washed-out, somewhat moth-eaten appearance.
- Posner-Schlossman syndrome, or glaucomatocyclitic crisis, may cause a lighter iris with repeated attacks.
- Pigment dispersion syndrome is a condition characterized by loss of pigmentation from the posterior iris surface. This pigment is dispersed throughout the interior of the eye and deposited on various intraocular structures, including the anterior surface of the iris, causing it to darken. This condition also causes pigmentary glaucoma.
- Trauma, either blunt or penetrating, may cause unilateral lightening of the iris through atrophy of the iris.
- Prostaglandin analogue eyedrops (Xalatan, Lumigan, Travatan, and others), frequently used for the treatment of glaucoma, may cause darkening of the iris, especially in people with light-colored irises. This occurs from the stimulation of melanin production. This type of medication is also sometimes used for cosmetic purposes (Latisse) to darken and thicken the eyelashes.
- Retained iron-containing intraocular foreign body may cause siderosis (iron deposition within the eye) resulting in a darker iris.
- Blood in the anterior chamber (hyphema) of long duration from trauma can lead to iron deposition in the iris from the breakdown of blood products.
- Ocular melanosis, or nevus of Ota, is a condition characterized by increased pigmentation of the eye and surrounding tissue.
- Iris ectropion syndrome is a condition in which the back of the iris, which is always dark and full of melanin pigment, turns onto the front of the iris through the pupillary space.
- Benign tumors of the iris, iris cysts, and iris abscesses can cause darkening or lightening of the iris.
- Malignant melanoma of the iris or metastatic tumors of the iris.
- Neovascular changes of the iris (rubeosis iridis) resulting from diabetes mellitus or following central retinal vein occlusion.
- Acquired Horner syndrome from neuroblastoma or injury/disease affecting the sympathetic nervous system in the neck.
- Chediak-Higashi syndrome is a rare genetic disorder that may manifest in childhood with recurrent infections, peripheral neuropathy, and color changes in the skin and eye.
- Clouding of the cornea or color changes in the cornea from a multitude of conditions may cause the iris to falsely appear to be different in color. Conditions such as corneal scars, the very common condition of arcus senilis, or the rare condition of Wilson disease can give the appearance of iris color differences.
Latest Eyesight News
- A Better Test to Help Spot Glaucoma?
- Cataracts: Common, and Easy to Treat
- Too Much Caffeine Might Raise Glaucoma Risk
- Man Blind for 40 Years Regains Some Sight
- Weight-Loss Surgery Might Help Prevent Cataracts
- Want More News? Sign Up for MedicineNet Newsletters!
Daily Health News
- H5N6 Bird Flu Infection in China
- COVID Vaccine Misinformation
- Antibiotic-Resistant Pneumonia
- Mask Mandate Returns to L.A.
- Fermented Foods Help Microbiome
More Health News »
Trending on MedicineNet
- Guillain-Barre Syndrome
- What Triggers Shingles?
- Normal Blood Sugar Levels
- Identify Tick Bites
- Why Is Autism Increasing?
How do health care professionals diagnose heterochromia iridis?
Heterochromia iris is usually noted by the parent of a baby or in acquired cases, by the patient or a family member. Diagnosis can be confirmed through slit lamp examination by an ophthalmologist.
Is there a treatment for heterochromia iridis?
If the heterochromia is secondary to an underlying cause such as inflammation, treatment should be directed at the underlying condition. In situations in which there is a major cosmetic impairment, a tinted contact lens may be used to darken the lighter appearing eye or lighten the darker appearing eye. Two differing colored contact lenses may also be used to arrive at an average color.
What is the prognosis of heterochromia iridis?
The vast majority of people with heterochromia iridis have an excellent prognosis and have no visual complaints. Most cases are very mild, nonprogressive, and unassociated with any other illness or eye disease. In patients with associated ocular or systemic problems, treatment of the underlying abnormality is often successful in preventing visual loss.